• Home
• Conference Coverage
• Conference Calendar
• UroToday International Journal
• Advanced Search

UroToday's Sexually Transmitted Disease section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of sexually transmitted diseases. Also available are conference coverage for all timely science on sexually transmitted diseases, audio podcasts and downloadable slides from UroToday's slide library. Online Urology & Urologic Oncology Journal Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Search    Display 5 10 15 20 25 30 50 results per page Results 76 - 85 of 85 << Start < Prev 1 2 3 4 5 6 Next > End >> New Rapid Test Developed To Detect Chlamydia Tuesday, 16 December 2003 LONDON (Reuters) - An international team of scientists has developed an easy-to-use, rapid test for chlamydia. read more U.S. Syphilis Rates Climb for the Second Year in a Row Thursday, 20 November 2003 NEW YORK (Reuters Health) - Overall, the syphilis rate rose in the United States by 9.1% between 2001 and 2002, according to new statistics released Thursday by the Centers for Disease Control and Prevention. read more HSV-1 May be Dominant Cause of Genital Herpes Wednesday, 05 November 2003 NEW YORK (Reuters Health) - Findings from two new studies add to growing evidence that herpes simplex virus type 1 (HSV-1) is now the principal cause of genital herpes. read more Circumcision Appears Protective Against HIV-1 Infection Friday, 10 October 2003 NEW YORK (Reuters Health) - The risk of being infected with HIV-1 is eight times higher among uncircumcised men compared with their circumcised counterparts, according to a "late breaker" presentation at the 41st Annual Meeting of the Infectious Diseases Society of America in San Diego. read more FDA Updates Labeling of Valtrex Friday, 29 August 2003 The Food and Drug Administration (FDA) has approved a new indication for Valtrex (valacyclovir hydrochloride) Caplets; Valtrex reduces the risk of heterosexual transmission of genital herpes to susceptible partners with healthy immune systems when used as suppressive therapy in combination with safer sex practices. read more U.S. FDA Okays Glaxo's Valtrex to Prevent Herpes Transmission Friday, 29 August 2003 WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved GlaxoSmithKline's drug Valtrex (valacyclovir) for use in preventing transmission of genital herpes. read more Officials Aim to Combat Jump in Sexually Transmitted Diseases in the Netherlands Wednesday, 25 June 2003 AMSTERDAM - Dutch health officials, alarmed at an "explosive" increase in sexually transmitted infections in the Netherlands, say they will change tactics to combat the trend. read more Sexual Health Crisis Looms in Britain, Politicians Say Tuesday, 10 June 2003 LONDON (Reuters Health) - Britain is facing a sexual health crisis with diseases like chlamydia, syphilis and gonorrhoea soaring, a parliamentary committee said on Wednesday. read more Tuberculosis Risk Depends on Duration of HIV Infection Tuesday, 10 June 2003 NEW YORK (Reuters Health) - Findings from a study of HIV-positive injecting drug users (IDU) in Europe indicate that the risk of tuberculosis varies according to the duration of HIV infection. The risk is highest 4 to 6 years and 9 years after infection. read more Pyrazinamide More Toxic Than Expected in Treatment of TB Friday, 06 June 2003 NEW YORK (Reuters Health) - The incidence of major adverse reactions to the antituberculosis drug pyrazinamide (PZA) is higher than for other first-line agents, results of a study conducted at the Montreal Chest Institute in Quebec suggest. read more Resource Center Editor's Top Picks We are pleased to introduce the new "Editor's Picks" section designed to highlight the most exciting breaking science and hottest news in Urology!   << Start < Prev 1 2 3 4 5 6 Next > End >> Results 76 - 85 of 85

UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810 About The Editors | About Us | Contact Us | Sponsorship Opportunities | Terms of Use Privacy Policy | © 2008 UroToday ® All Rights Reserved